Symrise (FRA:SY1) Given a €114.00 Price Target by The Goldman Sachs Group Analysts

Symrise (FRA:SY1Get Rating) has been assigned a €114.00 ($123.91) price objective by investment analysts at The Goldman Sachs Group in a note issued to investors on Monday, Borsen Zeitung reports. The Goldman Sachs Group’s price target would indicate a potential upside of 8.57% from the stock’s previous close.

A number of other research firms have also recently weighed in on SY1. Warburg Research set a €100.00 ($108.70) price target on Symrise in a report on Monday. Berenberg Bank set a €124.00 ($134.78) price target on Symrise in a report on Thursday. UBS Group set a €122.00 ($132.61) price objective on Symrise in a research note on Tuesday, January 10th. Barclays set a €115.00 ($125.00) price objective on Symrise in a research note on Friday, November 11th. Finally, Jefferies Financial Group set a €125.00 ($135.87) price objective on Symrise in a research note on Monday.

Symrise Stock Up 0.4 %

FRA SY1 opened at €105.00 ($114.13) on Monday. Symrise has a twelve month low of €56.96 ($61.91) and a twelve month high of €73.48 ($79.87). The stock has a 50-day moving average of €106.20 and a 200 day moving average of €105.36.

Symrise Company Profile

(Get Rating)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Featured Articles

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.